CoreStack Unveils New Cloud Assessment Product for MSPs
New Product Streamlines Multi-Cloud Assessments for Azure, AWS, and GCP BELLEVUE, Wash.–(BUSINESS WIRE)–#cloudgovernance–CoreStack, a global…
New Product Streamlines Multi-Cloud Assessments for Azure, AWS, and GCP BELLEVUE, Wash.–(BUSINESS WIRE)–#cloudgovernance–CoreStack, a global…
The agreement provides Alight with exclusive access to the leading social determinants of health dataset…
–Tai’s industry-leading Ai tools save brokers an average of 11 hours per week while securing…
Four RH&A partners also named to 2023 Texas Super Lawyers listing HOUSTON–(BUSINESS WIRE)–Texas legal legend…
Deal cements Avangrid as an early mover in single year as-generated credit transfers ORANGE, Conn.–(BUSINESS…
In-house hardware alternatives help overcome cost, compliance and control issues increasingly found in many cloud…
The round, led by Left Lane Capital and including General Catalyst and Labcorp Venture Fund,…
London UK, September 27, 2023 – Binah.ai, the number one health and wellness check software, and Endava (NYSE “DAVA”), a…
Trusted Advisors can win more business with AVANT by utilizing the game-changing platform CHICAGO, Sept….
The results from the NIPU study will be presented by the Principal Investigator as an…
The results from the NIPU study will be presented by the Principal Investigator as an…
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the…
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the…
FARMINGDALE, N.Y., Sept. 27, 2023 (GLOBE NEWSWIRE) — DepYmed, Inc. (“DepYmed” or the “Company”) is…
FARMINGDALE, N.Y., Sept. 27, 2023 (GLOBE NEWSWIRE) — DepYmed, Inc. (“DepYmed” or the “Company”) is…
One clinical poster detailing initial overall survival and immunological biomarker data from the ongoing, randomized,…
One clinical poster detailing initial overall survival and immunological biomarker data from the ongoing, randomized,…
BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company…
REDWOOD CITY, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS),…
Spotlight on Novel, Targeted Technologies to Enhance Engraftment, Expansion and Persistence of AlloCAR T™ Cells…